Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...

Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, today announced that its European patent EP3722434, ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...

Prof. Kabiru Akinyemi of the Department of Microbiology, Faculty of Science, Lagos State University (LASU) has sought the ...

This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...

Russian scientists have created a bacterial strain and a corresponding vaccine for animals that protects simultaneously against salmonellosis and colibacillosis, reports the official website of the ...

The company said the new chemistry could decrease sequencing costs for high-throughput users by up to 40%, lowering the ...

Asimov has introduced a new manufacturing platform aimed at improving the scalability and consistency of AAV production for gene therapies.

OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s ...